OMC
XBIT icon

Oasis Management Company’s XBiotech XBIT Stock Holding History

Oasis Management Company’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-137,174
Closed -$481K – 113
2022
Q4 		$481K Hold
137,174
– – 0.1% 69
2022
Q3 		$497K Hold
137,174
– – 0.08% 85
2022
Q2 		$772K Buy
+137,174
New +$923K 0.14% 63

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Oasis Management Company's XBIT Position: Q1 2023 in Review

Oasis Management Company sold out of XBiotech (XBIT) in Q1 2023, closing a stake of 137,174 shares — an estimated $481K sold.

Oasis Management Company first reported a position in XBIT in Q2 2022 and held it in 3 quarters. The position peaked at $772K in Q2 2022. 38 funds tracked by Wall St. Rank hold XBIT as of Q1 2023.

  • Oasis Management Company reported no remaining XBiotech position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 137,174 XBiotech shares in Q1 2023, an estimated $481K.
  • Oasis Management Company first reported a position in XBiotech in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's XBiotech position peaked at $772K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held XBiotech as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.